Abstract
In this issue of The Journal, Wolf et al1 raise several points relevant to hereditary hearing impairment, early identification of hearing impairment in infants, and the (potential) effect that novel molecular biologic and molecular genetic information can have on patient management. See related article, p 242.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
